SXTC
China Sxt Pharmaceuticals, Inc.
NASDAQ · Healthcare · Drug Manufacturers - Specialty & Generic · CN
$0.08
+24.00%Latest reported
- Last report date
- Mar 30, 2019
- EPS actual
- $0.07
- EPS estimate
- —
- Revenue actual
- $7.0M
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- —
- EPS misses (12Q)
- —
- EPS in line (12Q)
- —
- Avg surprise (4Q)
- —
- Revenue beats (12Q)
- —
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Mar 30, 2019 | — | $0.07 | — | $7.0M |
| Sep 29, 2018 | — | $0.05 | — | $3.9M |
| Dec 30, 2017 | — | $0.04 | — | $5.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 7, 2026